Javlor vs Vinorelbine: Side-by-Side Comparison
Quick answer: Javlor and Vinorelbine are both vinca alkaloid antineoplastic used for similar indications. They share a mechanism of action but differ in dosing, half-life, side-effect profile, and clinical preferences. Switching between them is a clinical decision.
Side-by-side comparison
| Feature | Javlor | Vinorelbine |
|---|---|---|
| Drug class | Vinca alkaloid antineoplastic | Vinca alkaloid antineoplastic |
| ATC code | L01CA05 | L01CA04 |
| Primary indications | Advanced or metastatic transitional cell carcinoma of the urothelial tract | Non-small cell lung cancer, Metastatic breast cancer |
| Mechanism | Vinflunine brand — binds tubulin and inhibits microtubule polymerization, arresting mitosis in cancer cells | Binds tubulin to inhibit microtubule assembly, causing mitotic arrest and apoptosis in dividing cancer cells |
| Common dose | 320 mg/m² IV every 3 weeks | 25-30 mg/m² IV weekly or 60-80 mg/m² oral weekly |
| Detail page | Javlor details → | Vinorelbine details → |
How to choose between Javlor and Vinorelbine
Both medicines belong to the same therapeutic class and address overlapping indications. Selection between them depends on:
- Patient-specific factors: age, kidney and liver function, other medications, allergies, comorbidities
- Specific clinical indication: some class members are preferred for particular conditions or guideline recommendations
- Dosing preference: once-daily vs twice-daily, oral vs injectable, food requirements
- Tolerability: individual side-effect profiles vary even within a class
- Drug interactions: patient's other medications may interact differently with each option
- Cost and availability: generic availability, insurance coverage, regional access
Should you switch?
Switching between class members is a clinical decision, not a self-help one. Reasons your prescriber may consider switching include:
- Inadequate response to current medication
- Side effects affecting quality of life
- New drug interactions due to a recently added medication
- Cost or availability changes
- Updated guidelines favoring a different option
Never switch medications, change dose, or stop without consulting your prescriber.
Related
All Vinca alkaloid antineoplastic on iMedic · Javlor full details · Vinorelbine full details
Frequently asked questions
Is Javlor better than Vinorelbine?
Neither is universally 'better.' They are both vinca alkaloid antineoplastic with similar mechanisms of action. The right choice depends on the specific clinical situation, patient factors, dosing preferences, drug interactions, and tolerability. Discuss with your prescriber.
Can I switch from Javlor to Vinorelbine?
Switching is possible but should be done under clinical supervision. Different class members may not be interchangeable on a 1:1 dose basis, and tapering or transition strategies vary. Never switch on your own.
Do Javlor and Vinorelbine have the same side effects?
They share class-wide side-effect tendencies but differ in individual profiles. Some patients tolerate one better than the other. Specific frequency and severity of side effects can be found on each medicine's individual page.
Are Javlor and Vinorelbine available as generics?
Generic availability depends on patent status in your country. Most well-established class members are available generically and are clinically equivalent to brand-name versions.
Last reviewed: by iMedic Medical Editorial Team. Our editorial process.